VarCov Co’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
Other funds holding BBIO
VarCov Co's BBIO Position: Q3 2026 in Review
VarCov Co increased its BridgeBio Pharma (BBIO) stake by 25% in Q3 2026, buying an estimated $98.5K and bringing the position to 6,285 shares worth $414K. The position accounts for 0.2% of the portfolio, ranked #183.
VarCov Co first reported a position in BBIO in Q4 2025 and has held it in 3 quarters since. 471 funds tracked by Wall St. Rank hold BBIO as of Q3 2026.
- VarCov Co held 6,285 shares of BridgeBio Pharma worth $414K as of Q3 2026.
- VarCov Co bought 1,265 BridgeBio Pharma shares in Q3 2026, an estimated $98.5K.
- BridgeBio Pharma made up 0.2% of VarCov Co's portfolio in Q3 2026, its #183 holding.
- VarCov Co first reported a position in BridgeBio Pharma in Q4 2025 and has held it in 3 quarters since.
- 471 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q3 2026.
Based on VarCov Co's 13F filing for Q3 2026, filed 16 Nov 2026.